Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Cardiology/Vascular Diseases | Hematology
Clinical Trials: Venous Thromboembolism
A listing of clinical trials currently looking for volunteers to enroll in Venous Thromboembolism studies. Click on the closest city to find more detailed information on a research study in your area.
Arizona
Glendale : Arrowhead Hospital/Phoenix Heart, PLLC
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Arkansas
California
Los Angeles :
Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects
Orange : St. Joseph Hospital
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Palo Alto : Stanford University Medical Center
Treatment of Blood Clots in Children With Cancer
San Diego :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Stanford : Stanford University Medical Center
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Colorado
Aurora : University Of Colorado Denver
Pediatric Catheter-related Thrombosis Imaging Study
Connecticut
Danbury : Danbury Hospital
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Norwich : Eastern Connecticut Hematology and Oncology Associates
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Delaware
Newark : Christiana Care Health Systems
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
District of Columbia
Florida
Jacksonville : Nemours Children's Clinic/Jacksonville
Treatment of Blood Clots in Children With Cancer
Orlando : Florida Hospital
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Tampa : Pepin Heart Hospital / University Community Hospital
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Tampa : St. Joseph's Children's Hospital of TampaPediatric Hematology/Oncology Research Department
Treatment of Blood Clots in Children With Cancer
Vero Beach :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Georgia
Atlanta : Emory University
Treatment of Blood Clots in Children With Cancer
Illinois
Chicago : University of Illinois at Chicago
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Chicago : Rush University Medical Center
Treatment of Blood Clots in Children With Cancer
Hinsdale : Adventist Midwest Health
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Springfield : Prairie Education and Research Cooperative
A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical Prophylaxis
Springfield : Southern Illinois University
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
View More »
Winfield : Central DuPage Hospital
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Indiana
Indianapolis : CorVasc
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Iowa
Iowa City : University of Iowa Carver's College of Medicine
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Kentucky
Maine
Portland : Maine Medical Center
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Maryland
Baltimore : Johns Hopkins Bayview Medical Center
A Pilot Study Comparing Enoxaparin to Fondaparinux to Prevent Venous Thromboembolism (VTE) in Bariatric Surgical Patients
Massachusetts
Boston : Massachusetts General Hospital
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Michigan
Ann Arbor : Ann Arbor Veteran's Administration Health System
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Ann Arbor : University of Michigan Medical Center
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Detroit : Henry Ford Health System
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Detroit : Detroit Medical Center
Fondaparinux in Critically Ill Patients With Renal Failure
Minnesota
Rochester : Mayo Clinic
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Missouri
Kansas City : Children'S Mercy Hospital And Clinics
Pediatric Catheter-related Thrombosis Imaging Study
St. Louis : Washington University School of Medicine
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Montana
Butte :
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
Nebraska
Lincoln : Saint Elizabeth Regional Medical Center
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
New Jersey
Teaneck : Holy Name Hospital
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
New Mexico
Albuquerque : University of New Mexico
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Albuquerque : University of New Mexico
Treatment of Blood Clots in Children With Cancer
New York
Buffalo : Roswell Park Cancer Institute
A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
New York : Cornell Weill Medical Center
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Rochester : University of Rochester Medical Center
A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
Rochester : Rochester General Hospital
A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
Staten Island : Staten Island University Hospital
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
North Carolina
Chapel Hill : University of North Carolina at Chapel Hill
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Durham : Duke University School of Medicine
A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
Durham : Duke University
Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism
Durham : Duke Children's Hospital
Treatment of Blood Clots in Children With Cancer
Winston Salem : Wake Forest University Baptist Medical Center
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
View More »
Winston-Salem : Forsyth Medical Center
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Ohio
Cincinatti : Good Samaritan Hospital
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Cincinnati : Cincinnati Children'S Hospital Medical Center
Pediatric Catheter-related Thrombosis Imaging Study
Cleveland : Cleveland Clinic
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Colombus : Univeristy Medical Center
STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism
Columbus : Riverside Methodist Hospital
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
View More »
Toledo : Jobst Vascular Center
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Oregon
Portland : Oregon Health & Science University
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Portland : Oregon Health and Science University
Treatment of Blood Clots in Children With Cancer
Pennsylvania
West Reading : The Reading Hospital and Medical Center Clinical Trials Office
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
View More »
Bethlehem : St. Luke's Hospital and Health Network
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Philadelphia : Albert Einstein Medical Center
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Philadelphia : Temple University Hospital
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Philadelphia : The Children'S Hospital Of Philadelphia
Pediatric Catheter-related Thrombosis Imaging Study
Pittsburgh : The Western Pennsylvania Hospital
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Pittsburgh : University of Pittsburgh Medical Center Presbyterian Shadyside
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Pittsburgh : Allegheny General Hospital
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Pittsburgh : Children'S Hopsital Of Pittsburgh Of Upmc
Pediatric Catheter-related Thrombosis Imaging Study
West Reading : The Reading Hospital and Medical Center
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Rhode Island
Providence : Rhode Island Hospital
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
South Carolina
Charleston : Medical University of South Carolina
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Charleston : Medical Center of South Carolina
STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism
Tennessee
Memphis : St. Jude Children's Research Hospital
Treatment of Blood Clots in Children With Cancer
Texas
Forth Worth : Cook Children's Medical Center
Treatment of Blood Clots in Children With Cancer
Houston : Texas Children'S Hospital
Pediatric Catheter-related Thrombosis Imaging Study
Houston : Ut Health/Gulf States Hemophilia & Thrombophilia Ctr.
Pediatric Catheter-related Thrombosis Imaging Study
Utah
Salt Lake City : University of Utah
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Virginia
Charlottesville : University of Virginia Health System
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Washington
Tacoma : MultiCare Health System
A Phase 3, Randomized, Parallel-Group, Multi-Center, Multi-National Study for the Evaluation of Efficacy and Safety of (LMW) Heparin/Edoxaban Versus (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis (DVT) and or Pulmonary Embolism (PE).
Wisconsin
Milwaukee : Medical College of Wisconsin/Froedtert Hospital
Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Argentina
Buenos Aires : Local Institution
Pediatric Catheter-related Thrombosis Imaging Study
Australia
Parkville :
Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects
Austria
Graz : 1160.86.43001 Boehringer Ingelheim Investigational Site
Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate
Many Locations :
Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy
Vienna : Local Institution
Pediatric Catheter-related Thrombosis Imaging Study
Wien :
Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects
Wien : 1160.89.43001 Boehringer Ingelheim Investigational Site
Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age
View More »
Wien : 1160.86.43003 Boehringer Ingelheim Investigational Site
Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate
Belgium
Brussel : 1160.89.32003 Boehringer Ingelheim Investigational Site
Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age
Brazil
Valinhos : LAL Clinica Pesquisa e Desenvolvimento Ltda
Efficacy And Safety Of Heparin In Patients With Cardiovascular Surgery Using Cardiopulmonary Bypass
Valinhos : LAL Clinica Pesquisa e Desenvolvimento Ltda
Efficacy And Safety Of Unfractionated Heparin In Patients With Cardiovascular Surgery Using Cardiopulmonary Bypass
Valinhos : Lal Clinica Pesquisa E Desenvolvimento Ltda
Efficacy of Sodium Heparin in Prophylaxis of Venous Thromboembolism in Surgical Patients
Canada
Charlottetown : 1160.86.01003 Boehringer Ingelheim Investigational Site
Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate
Edmonton : Local Institution
Pediatric Catheter-related Thrombosis Imaging Study
Edmonton :
Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects
Edmonton : 1160.89.00002 Boehringer Ingelheim Investigational Site
Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age
Hamilton :
Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects
View More »
Hamilton : St Joseph's Healthcare Hamilton
Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure
Montreal : SMBD Jewish General Hospital
Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism
Montréal : Maisonneuve Rosemont Hospital
STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism
Oshawa : Isis Investigational Site
Active Comparator-Controlled Study to Assess Safety and Efficacy of ISIS FXI Rx in Total Knee Arthroplasty
Ottawa : Ottawa Health Research Institute
Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism
Ottawa : Local Institution
Pediatric Catheter-related Thrombosis Imaging Study
Ottawa : 1160.89.00001 Boehringer Ingelheim Investigational Site
Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age
Ottawa : Ottawa Hospital, Parkdale Clinic
Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure
Red Deer : 1160.86.01001 Boehringer Ingelheim Investigational Site
Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate
Saskatoon : Saskatchewan Drug Research Institute
Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism
Toronto : Local Institution
Pediatric Catheter-related Thrombosis Imaging Study
Toronto : 1160.89.00005 Boehringer Ingelheim Investigational Site
Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age
Vancouver : Diamond Health Care Centre
Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer
Czech Republic
Brno : 1160.86.42001 Boehringer Ingelheim Investigational Site
Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate
Olomouc : 1160.86.42003 Boehringer Ingelheim Investigational Site
Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate
Prague : 1160.86.42004 Boehringer Ingelheim Investigational Site
Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate
Prague 5 : 1160.86.42002 Boehringer Ingelheim Investigational Site
Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate
Denmark
Many Locations :
Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy
Finland
Jyväskylä : 1160.86.35801 Boehringer Ingelheim Investigational Site
Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate
France
Brest : HIA Clermont-Tonnerre
Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)
Brest : Medical Intensive Care Unit
Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)
Castelnau Le Lez : Clinique du Parc CASTELNAU LE LEZ
National Evaluation of the Adherence to Recommendations of Venous Thrombo Embolism Treatment in Cancer Patients
Dijon : University Hospital
STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism
Grenoble : University Hospital
STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism
View More »
Lille : Medical Intensive Care Unit
Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)
Many Locations :
Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy
Marseille : 1160.89.33002 Boehringer Ingelheim Investigational Site
Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age
Paris : Medical Intensive Care Unit
Efficacy of the Association Mechanical Prophylaxis + Anticoagulant Prophylaxis on Venous Thromboembolism Incidence in Intensive Care Unit (ICU)
Paris : 1160.89.33001 Boehringer Ingelheim Investigational Site
Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age
Germany
Freiburg : Local Institution
Pediatric Catheter-related Thrombosis Imaging Study
Hannover : Local Institution
Pediatric Catheter-related Thrombosis Imaging Study
Many Locations :
Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy
India
Many Locations :
Xarelto for VTE Prophylaxis After Hip or Knee Arthroplasty
Israel
Tel Hashomer :
Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects
Italy
Bologna : University Hospital
STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism
Genova :
Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects
Milan : IRCCS H San Raffaele
STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism
Roma : 1160.89.39001 Boehringer Ingelheim Investigational Site
Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age
Japan
Aomori :
Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients
Bunkyo-ku :
Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients
Chuoku :
Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients
Fukuoka :
Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients
Itabashi-ku :
Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients
View More »
Kahoku-gun :
Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients
Kanazawa :
Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients
Kumamoto :
Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients
Maebashi :
Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients
Niigata :
Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients
Osaka :
Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients
Osakasayama :
Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients
Sakura :
Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients
Sapporo :
Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients
Sasebo :
Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients
Shinjuku-ku :
Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients
Shizuoka :
Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients
Tokushima :
Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients
Toyoake :
Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients
Tsu :
Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients
Wakayama :
Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients
Yokohama :
Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients
Korea, Republic of
Many Locations :
Xarelto Regulatory Post-Marketing Surveillance
Latvia
Riga : 1160.89.37101 Boehringer Ingelheim Investigational Site
Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age
Lithuania
Vilnius : 1160.89.37001 Boehringer Ingelheim Investigational Site
Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age
Mexico
Col. Secc Xvi Tlalpan : Local Institution
Pediatric Catheter-related Thrombosis Imaging Study
Monterrey : Local Institution
Pediatric Catheter-related Thrombosis Imaging Study
Netherlands
Amsterdam : Local Institution
Pediatric Catheter-related Thrombosis Imaging Study
Nijmegen : 1160.89.31003 Boehringer Ingelheim Investigational Site
Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age
Utrecht : 1160.89.31004 Boehringer Ingelheim Investigational Site
Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age
Norway
Bergen : 1160.89.47001 Boehringer Ingelheim Investigational Site
Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age
Russian Federation
Many locations :
Russian Non-Interventional Study on Compliance of Venous Thromboembolism (VTE)
Spain
Alicante : University Hospital
STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism
Madrid : 1160.89.34002 Boehringer Ingelheim Investigational Site
Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age
Madrid : 1160.89.34001 Boehringer Ingelheim Investigational Site
Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age
Many Locations :
Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy
Soria : General Hospital
STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism
Sweden
Hässleholm : 1160.86.46002 Boehringer Ingelheim Investigational Site
Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate
Many Locations :
Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy
Mölndal : 1160.86.46001 Boehringer Ingelheim Investigational Site
Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate
Stockholm : Karolinska University Hospital
Compression Treatment Effects on Complications and Healing of Achilles Tendon Rupture
Switzerland
Geneva : Hopitaux Universitaires de Geneve
Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism
Many Locations :
Treatment of an Acute Deep Vein Thrombosis (DVT) With Either Rivaroxaban or Current Standard of Care Therapy
Zürich : 1160.89.41001 Boehringer Ingelheim Investigational Site
Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age
Thailand
Bangkok : 1160.89.66001 Boehringer Ingelheim Investigational Site
Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age
Ukraine
Dnipropetrovsk : 1160.89.38001 Boehringer Ingelheim Investigational Site
Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age
Lugansk : 1160.89.38002 Boehringer Ingelheim Investigational Site
Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age
Vinnytsya : 1160.89.38003 Boehringer Ingelheim Investigational Site
Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age
United Kingdom
Glasgow : Local Institution
Pediatric Catheter-related Thrombosis Imaging Study
London : Local Institution
Pediatric Catheter-related Thrombosis Imaging Study
Vietnam
Many Locations :
Xarelto for VTE Prophylaxis After Hip or Knee Arthroplasty
